DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?

Detalhes bibliográficos
Autor(a) principal: Urbano, Filipa
Data de Publicação: 2023
Outros Autores: Simão, Carla
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.58043/rphrc.102
Resumo: Introduction: Metabolic syndrome is the combination of arterial hypertension, obesity, visceral adiposity, insulin resistance and dyslipidemia. These cardiovascular risk factors influence each other and the treatment of this syndrome as a whole is essential for the control of each of these factors. Non-pharmacological measures are the mainstay of treatment, followed by pharmacological therapy. Nevertheless, bariatric surgery has become an increasingly used complementary therapeutic approach, with good results, particularly in cases not controlled with conservative therapeutic measures. Case description: 14-year-old adolescent with a family history of cardiovascular risk, sedentary, with visceral obesity, insulin resistance, hepatic steatosis and a recent diagnosis of high blood pressure. The lack of control of the clinical situation with non-pharmacological and pharmacological therapy determined the bariatric surgery at 15 years old. Subsequent follow-up revealed global clinical improvement associated with a marked reduction in body mass index, normalization of blood pressure and insulin values, and improvement in hepatic steatosis. Additionally, there was an overall feeling of well-being after the surgery, with greater acceptance and adherence to non- pharmacological measures to control different risk factors, not verified before the surgery. Discussion: Metabolic syndrome has a polygenic cause and is associated with different modifiable and non-modifiable cardiovascular risk factors, whose global control is essential. Nevertheless, this factors’ association limits the effectiveness of isolated medical intervention and, in some cases, surgical therapy is essential. Bariatric surgery has been shown to be a successful method and should be accessible and done early. Conclusions: Acting early in the prevention of cardiovascular diseases represents the possibility of changing the natural history of these important systemic diseases.
id RCAP_d9a592a84a8c9c23a2509ef7e7be30e9
oai_identifier_str oai:ojs.revistahipertensao.pt:article/102
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?TERÁ A CIRURGIA BARIÁTRICA UM PAPEL NA SÍNDROME METABÓLICA EM PEDIATRIA?hipertensão essencialsíndrome metabólicaobesidade pediátricadoenças cardiovascularescirurgia bariátricacomportamentos de redução do riscoessential hypertensionmetabolic syndromepediatric obesitycardiovascular diseasesbariatric surgeryrisk reduction behaviorIntroduction: Metabolic syndrome is the combination of arterial hypertension, obesity, visceral adiposity, insulin resistance and dyslipidemia. These cardiovascular risk factors influence each other and the treatment of this syndrome as a whole is essential for the control of each of these factors. Non-pharmacological measures are the mainstay of treatment, followed by pharmacological therapy. Nevertheless, bariatric surgery has become an increasingly used complementary therapeutic approach, with good results, particularly in cases not controlled with conservative therapeutic measures. Case description: 14-year-old adolescent with a family history of cardiovascular risk, sedentary, with visceral obesity, insulin resistance, hepatic steatosis and a recent diagnosis of high blood pressure. The lack of control of the clinical situation with non-pharmacological and pharmacological therapy determined the bariatric surgery at 15 years old. Subsequent follow-up revealed global clinical improvement associated with a marked reduction in body mass index, normalization of blood pressure and insulin values, and improvement in hepatic steatosis. Additionally, there was an overall feeling of well-being after the surgery, with greater acceptance and adherence to non- pharmacological measures to control different risk factors, not verified before the surgery. Discussion: Metabolic syndrome has a polygenic cause and is associated with different modifiable and non-modifiable cardiovascular risk factors, whose global control is essential. Nevertheless, this factors’ association limits the effectiveness of isolated medical intervention and, in some cases, surgical therapy is essential. Bariatric surgery has been shown to be a successful method and should be accessible and done early. Conclusions: Acting early in the prevention of cardiovascular diseases represents the possibility of changing the natural history of these important systemic diseases.Introdução: À combinação de hipertensão arterial, obesidade, adiposidade visceral, resistência à insulina e dislipidémia denomina-se síndrome metabólica. Dada a influência dos vários fatores de risco cardiovasculares entre si, o tratamento da síndrome metabólica como um todo é fundamental para o controlo de cada um desses fatores. As medidas não farmacológicas são o pilar do tratamento, seguidas da terapêutica farmacológica. Contudo, a cirurgia bariátrica tem-se tornado uma abordagem terapêutica complementar cada vez mais utilizada, com bons resultados, nomeadamente nos casos não controladas com medidas terapêuticas conservadoras. Descrição do caso: Adolescente de 14 anos com antecedentes familiares de risco cardiovascular, sedentária, com obesidade visceral, resistência à insulina, esteatose hepática e com o diagnóstico recente de pressão arterial elevada. A ausência de controlo da situação clinica com terapêutica não farmacológica e farmacológica determinou a realização de cirurgia bariátrica aos 15 anos. O acompanhamento subsequente revelou melhoria clínica global associada a uma redução importante do índice de massa corporal, normalização dos valores de pressão arterial e de insulina e melhoria da esteatose hepática. Adicionalmente, verificou-se uma sensação global de bem estar após a cirurgia, que condicionou maior aceitação e adesão às medidas não farmacológicas de controlo dos diferentes fatores de risco, não objetivada antes da cirurgia. Discussão: A síndrome metabólica tem causa poligénica e está associada a diferentes fatores de risco cardiovasculares, modificáveis e não modificáveis, cujo controlo global é essencial. Contudo, essa associação de fatores limita a eficácia da intervenção médica isolada e em alguns casos a terapêutica cirúrgica é fundamental. A cirurgia bariátrica tem-se demonstrado um método de sucesso e deve ser acessível e precoce. Conclusões: Agir precocemente na prevenção das doenças cardiovasculares representa a possibilidade de modificar a história natural destas importantes doenças sistémicas.Revista Portuguesa de Hipertensão e Risco Cardiovascular2023-10-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.58043/rphrc.102https://doi.org/10.58043/rphrc.102Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 97 (2023): Setembro/Outubro; 18-231646-8287reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revistahipertensao.pt/index.php/rh/article/view/102https://revistahipertensao.pt/index.php/rh/article/view/102/89Direitos de Autor (c) 2023 Filipa Urbanoinfo:eu-repo/semantics/openAccessUrbano, FilipaSimão, Carla2023-12-09T07:20:31Zoai:ojs.revistahipertensao.pt:article/102Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:39:17.274267Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
TERÁ A CIRURGIA BARIÁTRICA UM PAPEL NA SÍNDROME METABÓLICA EM PEDIATRIA?
title DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
spellingShingle DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
Urbano, Filipa
hipertensão essencial
síndrome metabólica
obesidade pediátrica
doenças cardiovasculares
cirurgia bariátrica
comportamentos de redução do risco
essential hypertension
metabolic syndrome
pediatric obesity
cardiovascular diseases
bariatric surgery
risk reduction behavior
title_short DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
title_full DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
title_fullStr DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
title_full_unstemmed DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
title_sort DOES BARIATRIC SURGERY HAVE A ROLE IN THE METABOLIC SYNDROME IN PEDIATRICS?
author Urbano, Filipa
author_facet Urbano, Filipa
Simão, Carla
author_role author
author2 Simão, Carla
author2_role author
dc.contributor.author.fl_str_mv Urbano, Filipa
Simão, Carla
dc.subject.por.fl_str_mv hipertensão essencial
síndrome metabólica
obesidade pediátrica
doenças cardiovasculares
cirurgia bariátrica
comportamentos de redução do risco
essential hypertension
metabolic syndrome
pediatric obesity
cardiovascular diseases
bariatric surgery
risk reduction behavior
topic hipertensão essencial
síndrome metabólica
obesidade pediátrica
doenças cardiovasculares
cirurgia bariátrica
comportamentos de redução do risco
essential hypertension
metabolic syndrome
pediatric obesity
cardiovascular diseases
bariatric surgery
risk reduction behavior
description Introduction: Metabolic syndrome is the combination of arterial hypertension, obesity, visceral adiposity, insulin resistance and dyslipidemia. These cardiovascular risk factors influence each other and the treatment of this syndrome as a whole is essential for the control of each of these factors. Non-pharmacological measures are the mainstay of treatment, followed by pharmacological therapy. Nevertheless, bariatric surgery has become an increasingly used complementary therapeutic approach, with good results, particularly in cases not controlled with conservative therapeutic measures. Case description: 14-year-old adolescent with a family history of cardiovascular risk, sedentary, with visceral obesity, insulin resistance, hepatic steatosis and a recent diagnosis of high blood pressure. The lack of control of the clinical situation with non-pharmacological and pharmacological therapy determined the bariatric surgery at 15 years old. Subsequent follow-up revealed global clinical improvement associated with a marked reduction in body mass index, normalization of blood pressure and insulin values, and improvement in hepatic steatosis. Additionally, there was an overall feeling of well-being after the surgery, with greater acceptance and adherence to non- pharmacological measures to control different risk factors, not verified before the surgery. Discussion: Metabolic syndrome has a polygenic cause and is associated with different modifiable and non-modifiable cardiovascular risk factors, whose global control is essential. Nevertheless, this factors’ association limits the effectiveness of isolated medical intervention and, in some cases, surgical therapy is essential. Bariatric surgery has been shown to be a successful method and should be accessible and done early. Conclusions: Acting early in the prevention of cardiovascular diseases represents the possibility of changing the natural history of these important systemic diseases.
publishDate 2023
dc.date.none.fl_str_mv 2023-10-19
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.58043/rphrc.102
https://doi.org/10.58043/rphrc.102
url https://doi.org/10.58043/rphrc.102
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistahipertensao.pt/index.php/rh/article/view/102
https://revistahipertensao.pt/index.php/rh/article/view/102/89
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Filipa Urbano
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Filipa Urbano
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Revista Portuguesa de Hipertensão e Risco Cardiovascular
publisher.none.fl_str_mv Revista Portuguesa de Hipertensão e Risco Cardiovascular
dc.source.none.fl_str_mv Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 97 (2023): Setembro/Outubro; 18-23
1646-8287
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133653820768256